Using a Cox proportional hazards model, higher ITGAE expression was also significantly associated with poorer survival in adrenocortical carcinoma as well as in primary cutaneous melanoma, breast carcinoma, kidney renal cell carcinoma and kidney chromophobe cancer (online supplemental figure 8C). This evidence concerns the gene ITGAE and adrenal cortex carcinoma.